Showing results (221-230 of 372) with videos related to
Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|April 15, 1993
Acquired multicellular-mediated resistance to alkylating agents in cancerH Kobayashi, S Man, C H Graham, et al.Oncology Research|January 1, 1996
Lisofylline as a modifier of radiation therapyJ S Wong, G Ara, S R Keyes, et al.International Journal of Oncology|November 15, 2011
Human choriocarcinomas: placental growth factor-dependent preclinical tumor modelsRebecca G Bagley, Yi Ren, Leslie Kurtzberg, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 26, 2004
Murine endothelial cell lines as models of tumor endothelial cellsJennifer Walter-Yohrling, Sharon Morgenbesser, Cecile Rouleau, et al.Photochemistry and Photobiology|April 1, 1992
Multiple modality treatment of carcinoma cells with Pt(Rh-123)2 plus x-ray plus lightG Ara, A Varshney, C S Ha, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1992
A new concentrated perfluorochemical emulsion and carbogen breathing as an adjuvant to treatment with antitumor alkylating agentsB A Teicher, S A Holden, G Ara, et al.Cancer Research|September 1, 1986
Alkylating agents: in vitro studies of cross-resistance patterns in human cell linesB A Teicher, C A Cucchi, J B Lee, et al.Cancer Research|October 3, 2002
An in vitro tumor model: analysis of angiogenic factor expression after chemotherapyKristan Keyes, Karen Cox, Patti Treadway, et al.International Journal of Cancer|March 28, 1997
Reversal of in vivo drug resistance by the transforming growth factor-beta inhibitor decorinB A Teicher, Y Maehara, Y Kakeji, et al.Seminars in Oncology|December 22, 1999
MTA (LY231514) in combination treatment regimens using human tumor xenografts and the EMT-6 murine mammary carcinomaB A Teicher, E Alvarez, P Liu, et al.Pageof 38